Fanconi-Bickel 综合征(FBS, OMIM 227810)是一种常染色体隐性遗传的罕见糖代谢异常疾病,致病基因为SLC2A2。该文报道3 例经SLC2A2 基因分析确诊的FBS 病例。3 例患儿表现为典型的糖原累积症及近端肾小管功能障碍表现。基因测序显示1 例为纯合剪接突变IVS8+5G>C(c.1068+5 G>C);1 例为纯合无义突变c.1194T>A(p.Tyr398X);1 例为错义突变c.380C>A(p.Ala127Asp)和重复突变c.970dupT(p.324TyrfsX392),其中c.970dupT(p.324TyrfsX392)非经父母遗传,为新生突变。该4 种突变中,除IVS8+5G>C 外,其余3 种为中国人种FBS 新突变,而c.970dupT(p.324TyrfsX392)可能为世界首例FBS 新生突变报道。
Abstract
Fanconi-Bickel syndrome (FBS, OMIM 227810), a rare autosomal recessive disorder of carbohydrate metabolism, is caused by SLC2A2 (GLUT2) mutations. The study reported 3 cases of FBS who were confirmly diagnosed by SLC2A2 gene analysis. The three patients showed typical features like glycogen storage disease and proximal renal tubular nephropathy. Homozygous splice-site mutation IVS8+5G>C (c.1068+5 G>C) was found in patient A and homozygous nonsense mutation c.1194T>A (p.Tyr398X) in patient B. Patient C harboured a missense mutation c.380C>A (p.Ala127Asp) and a de novo insertion c.970dupT (p.324TyrfsX392) which was not inherited from her parents. Four mutations were identified in the 3 Chinese FBS patients. Except IVS8+5G>C mutation, the other 3 mutations were novel in Chinese population. To the best of our knowledge, patient C may be the first FBS case worldwide with de novo mutation.
关键词
Fanconi-Bickel 综合征 /
SLC2A2 /
新生突变 /
中国人种 /
儿童
Key words
Fanconi-Bickel syndrome /
SLC2A2 /
De novo mutation /
Chinese population /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Santer R, Schneppenheim R, Suter D, et al. Fanconi-Bickel syndrome—the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature[J]. Eur J Pediatr, 1998, 157(10): 783-797.
[2] Santer R, Schneppenheim R, Dombrowski A, et al. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome[J]. Nat Genet, 1997, 17(3): 324-326.
[3] Mueckler M, Kruse M, Strube M, et al. A mutation in the Glut2 glucose transporter gene of a diabetic patient abolishes transport activity[J]. J Biol Chem, 1994, 269(27): 17765-17767.
[4] Takeda J, Kayano T, Fukomoto H, et al. Organization of the human GLUT2 (pancreatic beta-cell and hepatocyte) glucose transporter gene[J]. Diabetes, 1993, 42(5): 773-777.
[5] 张乐嘉, 邱正庆, 丁国芳, 等. Fanconi-Bickel 综合征1 例并文献复习[J]. 实用儿科临床杂志, 2011, 26(24): 1882-1884.
[6] Fanconi G, Bickel H. Die chronische Aminoacidurie (Aminosaeurediabetes oder nephrotisch-glukosurischer Zwergwuchs) bei der Glykogenose und der Cystinkrankheit[J]. Helv Paediat Acta, 1949, 4(5): 359-396.
[7] Santer R, Groth S, Kinner M, et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome[J]. Hum Genet, 2002, 110(1): 21-29.
[8] von Schnakenburg C, Santer R. Fanconi-Bickel syndrome and fertility[J]. Am J Med Genet A, 2011, 155A(10): 2607.
[9] Murphy N, Elramah M, Vats H, et al. A case report of deferasirox-induced kidney injury and Fanconi syndrome[J]. WMJ, 2013, 112(4): 177-180.
[10] Leturque A, Brot-Laroche E, Le Gall M. GLUT2 mutations, translocation, and receptor function in diet sugar managing[J]. Am J Physiol Endocrinol Metab, 2009, 296(5): E985-E992.
[11] Su Z, Du ML, Chen HS, et al. Two cases of Fanconi-Bickel syndrome: first report from China with novel mutations of SLC2A2 gene[J]. J Pediatr Endocrinol Metab, 2011, 24(9-10): 749-753.